Jiandong Yu

446 total citations
30 papers, 332 citations indexed

About

Jiandong Yu is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Jiandong Yu has authored 30 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Jiandong Yu's work include Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (4 papers) and Natural product bioactivities and synthesis (3 papers). Jiandong Yu is often cited by papers focused on Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (4 papers) and Natural product bioactivities and synthesis (3 papers). Jiandong Yu collaborates with scholars based in China, United States and Hong Kong. Jiandong Yu's co-authors include Shuang‐Cheng Ma, Yang Xiong, Yun-Le Wan, Yunle Wan, Rui‐Chao Lin, Xinyue Xiao, Pang‐Chui Shaw, Shiying Yang, Paul Pui‐Hay But and Qi Liu and has published in prestigious journals such as Scientific Reports, International Journal of Pharmaceutics and Journal of Cellular Physiology.

In The Last Decade

Jiandong Yu

29 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiandong Yu China 10 169 52 43 41 40 30 332
Yuzhong Chen China 11 125 0.7× 40 0.8× 54 1.3× 22 0.5× 23 0.6× 22 283
Xinfang Zhang China 7 144 0.9× 42 0.8× 42 1.0× 52 1.3× 36 0.9× 21 322
Junjie Lan China 12 175 1.0× 116 2.2× 48 1.1× 75 1.8× 40 1.0× 25 389
Linwei Chen China 10 128 0.8× 30 0.6× 37 0.9× 37 0.9× 10 0.3× 41 432
Shu‐Hsin Chen Taiwan 12 192 1.1× 51 1.0× 61 1.4× 41 1.0× 18 0.5× 17 378
Runlan Luo China 8 144 0.9× 59 1.1× 29 0.7× 20 0.5× 14 0.3× 17 313
Cristina Mesas Spain 12 211 1.2× 120 2.3× 94 2.2× 23 0.6× 31 0.8× 47 459
Xiaoping Zeng China 13 299 1.8× 74 1.4× 83 1.9× 60 1.5× 97 2.4× 33 544
Bin Wen China 11 240 1.4× 61 1.2× 94 2.2× 83 2.0× 36 0.9× 21 407
Mirazul Islam Bangladesh 9 133 0.8× 51 1.0× 28 0.7× 27 0.7× 24 0.6× 21 308

Countries citing papers authored by Jiandong Yu

Since Specialization
Citations

This map shows the geographic impact of Jiandong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiandong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiandong Yu more than expected).

Fields of papers citing papers by Jiandong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiandong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiandong Yu. The network helps show where Jiandong Yu may publish in the future.

Co-authorship network of co-authors of Jiandong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiandong Yu. A scholar is included among the top collaborators of Jiandong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiandong Yu. Jiandong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jiandong, Tongtong Li, Xiangjun Shi, et al.. (2025). ETMO-NAS: An efficient two-step multimodal one-shot NAS for lung nodules classification. Biomedical Signal Processing and Control. 104. 107479–107479.
2.
Yu, Jiandong, Jiayan Wu, Lihong Lv, et al.. (2025). Donor liver natural killer cells ameliorate liver allograft rejection via inducing apoptosis of alloreactive CD8+ T cells generating CD4+CD25+ regulatory T cells. Scientific Reports. 15(1). 23499–23499. 1 indexed citations
3.
Liu, Jingjing, Jianbo Yang, Ying Wang, et al.. (2024). Integrating network pharmacology and experimental validation to investigate the effects and mechanism of Renshen Shouwu decoction for ameliorating Alzheimer’s disease. Pharmaceutical Biology. 62(1). 767–780. 1 indexed citations
4.
Yu, Jiandong, et al.. (2024). LncRNA HOXB-AS3 promotes proliferation, migration, and invasion of gallbladder cancer cells by activating the MEK/ERK pathway. Heliyon. 10(16). e35906–e35906. 1 indexed citations
5.
Zhang, Yiran, Huiming Yang, Peng Yin, et al.. (2024). Increased expression of mesencephalic astrocyte-derived neurotrophic factor (MANF) contributes to synapse loss in Alzheimer’s disease. Molecular Neurodegeneration. 19(1). 75–75. 3 indexed citations
6.
Chen, Qin, Guolin Li, Jiandong Yu, et al.. (2023). The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer. Frontiers in Medicine. 10. 1205897–1205897. 8 indexed citations
7.
Zan, Ke, et al.. (2023). Distribution, determination method, risk assessment, and strategy of exogenous pyrrolizidine alkaloids in tea. Pharmacological Research - Modern Chinese Medicine. 8. 100277–100277. 2 indexed citations
8.
Lin, Zeyu, et al.. (2022). Mitofusin-2 Restrains Hepatic Stellate Cells’ Proliferation via PI3K/Akt Signaling Pathway and Inhibits Liver Fibrosis in Rats. Journal of Healthcare Engineering. 2022. 1–11. 9 indexed citations
9.
Chen, Zhiping, Jiandong Yu, Jiayan Wu, et al.. (2022). MiR-195-5p suppresses the proliferation, migration, and invasion of gallbladder cancer cells by targeting FOSL1 and regulating the Wnt/β-catenin pathway. Annals of Translational Medicine. 10(16). 893–893. 9 indexed citations
10.
Yu, Jiandong, Lisha Ma, Yue Zhao, et al.. (2022). Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy. International Journal of Pharmaceutics. 624. 121931–121931. 7 indexed citations
11.
Gu, Hongqiu, Xuewei Xie, Jing Jing, et al.. (2020). Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design. Stroke and Vascular Neurology. 5(3). 311–314. 7 indexed citations
12.
Yu, Jiandong, et al.. (2020). [Evaluation of clinical application of transjugular liver biopsy in 61 cases].. PubMed. 28(11). 949–953. 2 indexed citations
13.
Ying, Wang, Hongyu Jin, Jiandong Yu, et al.. (2020). Quality control and immunological activity of lentinan samples produced in China. International Journal of Biological Macromolecules. 159. 129–136. 31 indexed citations
14.
15.
16.
Yu, Jiandong, Zhi Chen, Mancang Gu, et al.. (2018). Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism. European Journal of Pharmaceutical Sciences. 120. 20–29. 27 indexed citations
17.
Tang, Jian, et al.. (2012). Inflammatory Myofibroblastic Tumor of the Liver Following Renal Transplantation. Renal Failure. 34(6). 789–791. 9 indexed citations
18.
Lv, Lihong, Jiandong Yu, Guolin Li, et al.. (2012). Functional distinction of rat liver natural killer cells from spleen natural killer cells under normal and acidic conditions in vitro. Hepatobiliary & pancreatic diseases international. 11(3). 285–293. 15 indexed citations
19.
Yu, Jiandong, et al.. (2011). Donor liver natural killer cells alleviate liver allograft acute rejection in rats. Hepatobiliary & pancreatic diseases international. 10(4). 386–392. 11 indexed citations
20.
Cheng, Xian‐Long, Shuang‐Cheng Ma, Jiandong Yu, et al.. (2008). Selaginellin A and B, Two Novel Natural Pigments Isolated from Selaginella tamariscina. Chemical and Pharmaceutical Bulletin. 56(7). 982–984. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuzhong Chen Breakdown of academic impact, for papers by Xinfang Zhang Breakdown of academic impact, for papers by Junjie Lan Breakdown of academic impact, for papers by Linwei Chen Breakdown of academic impact, for papers by Shu‐Hsin Chen Breakdown of academic impact, for papers by Runlan Luo Breakdown of academic impact, for papers by Cristina Mesas Breakdown of academic impact, for papers by Xiaoping Zeng Breakdown of academic impact, for papers by Bin Wen Breakdown of academic impact, for papers by Mirazul Islam
Rankless by CCL
2026